| 0 (0%) | 01-14 09:37 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 131.15 | 1-year : | 153.18 |
| Resists | First : | 112.29 | Second : | 131.15 |
| Pivot price | 102.8  |
|||
| Supports | First : | 100.7 | Second : | 93.54 |
| MAs | MA(5) : | 106.62 |
MA(20) : | 101.77 |
| MA(100) : | 94.12 |
MA(250) : | 78.53 |
|
| MACD | MACD : | 1.7 |
Signal : | 1.2 |
| %K %D | K(14,3) : | 54.7 |
D(3) : | 62.1 |
| RSI | RSI(14): 52.7 |
|||
| 52-week | High : | 112.29 | Low : | 53.56 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ INCY ] has closed below upper band by 45.5%. Bollinger Bands are 32.4% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 107.67 - 108.34 | 108.34 - 108.82 |
| Low: | 101.11 - 101.93 | 101.93 - 102.51 |
| Close: | 102.35 - 103.55 | 103.55 - 104.4 |
Wed, 14 Jan 2026
Is Incyte (INCY) Still Attractively Priced After Its Strong 1 Year Share Price Gain? - Yahoo Finance
Tue, 13 Jan 2026
Incyte (INCY) Receives Updated Buy Rating from TD Cowen | INCY S - GuruFocus
Tue, 13 Jan 2026
Incyte (INCY) PT Raised to $128 at TD Cowen - StreetInsider
Mon, 12 Jan 2026
How Positive frontMIND Phase 3 DLBCL Data May Reshape Incyte’s (INCY) Oncology Pipeline Story - simplywall.st
Mon, 12 Jan 2026
Lobbying Update: $70,000 of INCYTE CORPORATION lobbying was just disclosed - Quiver Quantitative
Mon, 12 Jan 2026
Will Incyte (INCY) Beat Estimates Again in Its Next Earnings Report? - Finviz
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 196 (M) |
| Shares Float | 164 (M) |
| Held by Insiders | 1.9 (%) |
| Held by Institutions | 105.6 (%) |
| Shares Short | 10,750 (K) |
| Shares Short P.Month | 9,500 (K) |
| EPS | 5.9 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 23.71 |
| Profit Margin | 24.7 % |
| Operating Margin | 31.6 % |
| Return on Assets (ttm) | 13.5 % |
| Return on Equity (ttm) | 30.3 % |
| Qtrly Rev. Growth | 20 % |
| Gross Profit (p.s.) | 13.85 |
| Sales Per Share | 24.5 |
| EBITDA (p.s.) | 6.72 |
| Qtrly Earnings Growth | 290.7 % |
| Operating Cash Flow | 1,250 (M) |
| Levered Free Cash Flow | 531 (M) |
| PE Ratio | 17.53 |
| PEG Ratio | 0 |
| Price to Book value | 4.36 |
| Price to Sales | 4.22 |
| Price to Cash Flow | 16.24 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|